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Background: Prior studies suggest increased mortality among young women experiencing acute coronary syndromes (ACS); however, data on 
characteristics which place younger women at risk is limited.
Methods: We examined data from 3,237 men and women admitted to the University of Michigan Health System with an ACS event from January 
1999 to December 2006. Women were grouped by age into a younger group < 55 years of age and those 55 years or older. Demographics, 
medications on admission, in-hospital management and outcomes at six-month were included in the analysis. The primary outcomes of interest 
included cardiac related rehospitalization, revascularization, recurrent myocardial infarction (MI), and death.
Results: Women under 55 years old represented 7.8% of the cohort. Compared to older women and men, younger women were more likely 
to be current smokers (p< .001) and obese (p< .001), but less like to have a prior history of cardiac disease, hypertension or stroke. Rates of 
hyperlipidemia were similar between the three groups. Younger women were less likely to receive lytic therapy or percutaneous coronary interventions. 
Upon discharge, younger women were less likely to receive beta blockers (p< .001), ace-inhibitors/ARBs (p≤.001), lipid-lowering therapies (p< .001) 
or clopidogrel (p< .001) as compared to older women or men. At six months, mortality rates were lowest among younger women; however, rates of 
recurrent MI were statistically similar for the three groups. Rates of revascularization were highest among young women (37.4% for younger women, 
33.2% for older women, and 27.6% for men, p < 0.001). Only serum creatinine predicted rehospitalization rates among younger women (OR 1.37, 
95% CI 1.06 - 1.76); while prior history of heart failure (p = .002), MI (p = .049), PCI (p = .004) and history of smoking (p = .008) were predictors of 
rehospitalization among older women.
Conclusion: Young women presenting with ACS have high rates of rehospitalization. Younger women are less likely to receive evidence 
based medications and more likely to be readmitted within six-months after ACS. Further research is warranted to understand predictors of 
rehospitalization among younger women.
